Keith Vrbicky, MD, Enrolls First Participant in Moderna’s Phase II COVID-19 Vaccine Clinical Trial

The first participant in the Moderna Phase II COVID-19 vaccine trial was enrolled this morning by Keith Vrbicky, MD, Meridian Principal Investigator in Norfolk, NE. Congratulations to Moderna for making remarkable progress on its mRNA vaccine against novel coronavirus. 📰 Full release: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-each-age-cohort-dosed-phase